questionsmedicales.fr
Acides aminés, peptides et protéines
Protéines
Protéines mitochondriales
Protéines mitochondriales : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Dysfonction mitochondriale
Biopsie musculaire
Fatigue
Maladies mitochondriales
Tests génétiques
Mutations
Imagerie par résonance magnétique
Anomalies cérébrales
Symptômes
5
Troubles cognitifs
Dysfonction mitochondriale
Myopathie mitochondriale
Faiblesse musculaire
Cardiomyopathies
Dysfonctionnements mitochondriaux
Âge d'apparition
Variabilité des symptômes
Prévention
5
Prévention
Mode de vie sain
Exercice physique
Santé mitochondriale
Antioxydants
Dommages oxydatifs
Alimentation équilibrée
Nutriments
Dépistage précoce
Intervention rapide
Traitements
5
Suppléments
Thérapies symptomatiques
Coenzyme Q10
Fonction mitochondriale
Thérapie génique
Recherche
Régimes alimentaires
Fonction mitochondriale
Types de maladies mitochondriales
Adaptation des traitements
Complications
5
Complications
Troubles neurologiques
Fertilité
Maladies mitochondriales
Gestion des complications
Traitements symptomatiques
Risque de cancer
Dysfonction mitochondriale
Complications cardiovasculaires
Cardiomyopathies
Facteurs de risque
5
Antécédents familiaux
Mutations génétiques
Âge
Maladies mitochondriales
Facteurs environnementaux
Toxines
Stress oxydatif
Dommages mitochondriaux
Habitudes alimentaires
Dysfonction mitochondriale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Protéines mitochondriales : Questions médicales les plus fréquentes",
"headline": "Protéines mitochondriales : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Protéines mitochondriales : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-12",
"dateModified": "2025-04-07",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Protéines mitochondriales"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Protéines",
"url": "https://questionsmedicales.fr/mesh/D011506",
"about": {
"@type": "MedicalCondition",
"name": "Protéines",
"code": {
"@type": "MedicalCode",
"code": "D011506",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Aldehyde dehydrogenase, mitochondrial",
"alternateName": "Aldehyde Dehydrogenase, Mitochondrial",
"url": "https://questionsmedicales.fr/mesh/D000071396",
"about": {
"@type": "MedicalCondition",
"name": "Aldehyde dehydrogenase, mitochondrial",
"code": {
"@type": "MedicalCode",
"code": "D000071396",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.093"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitochondrial creatine kinase",
"alternateName": "Creatine Kinase, Mitochondrial Form",
"url": "https://questionsmedicales.fr/mesh/D052281",
"about": {
"@type": "MedicalCondition",
"name": "Mitochondrial creatine kinase",
"code": {
"@type": "MedicalCode",
"code": "D052281",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.186"
}
}
},
{
"@type": "MedicalWebPage",
"name": "DNA Polymerase gamma",
"alternateName": "DNA Polymerase gamma",
"url": "https://questionsmedicales.fr/mesh/D000074002",
"about": {
"@type": "MedicalCondition",
"name": "DNA Polymerase gamma",
"code": {
"@type": "MedicalCode",
"code": "D000074002",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.280"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Ferrochelatase",
"alternateName": "Ferrochelatase",
"url": "https://questionsmedicales.fr/mesh/D005294",
"about": {
"@type": "MedicalCondition",
"name": "Ferrochelatase",
"code": {
"@type": "MedicalCode",
"code": "D005294",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.562"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines de transport de la membrane mitochondriale",
"alternateName": "Mitochondrial Membrane Transport Proteins",
"url": "https://questionsmedicales.fr/mesh/D033681",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de transport de la membrane mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D033681",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Mitochondrial ADP, ATP Translocases",
"alternateName": "Mitochondrial ADP, ATP Translocases",
"url": "https://questionsmedicales.fr/mesh/D000226",
"about": {
"@type": "MedicalCondition",
"name": "Mitochondrial ADP, ATP Translocases",
"code": {
"@type": "MedicalCode",
"code": "D000226",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Translocateur-1 de nucléotides adényliques",
"alternateName": "Adenine Nucleotide Translocator 1",
"url": "https://questionsmedicales.fr/mesh/D033741",
"about": {
"@type": "MedicalCondition",
"name": "Translocateur-1 de nucléotides adényliques",
"code": {
"@type": "MedicalCode",
"code": "D033741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Translocateur-2 de nucléotides adényliques",
"alternateName": "Adenine Nucleotide Translocator 2",
"url": "https://questionsmedicales.fr/mesh/D033742",
"about": {
"@type": "MedicalCondition",
"name": "Translocateur-2 de nucléotides adényliques",
"code": {
"@type": "MedicalCode",
"code": "D033742",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Translocateur-3 de nucléotides adényliques",
"alternateName": "Adenine Nucleotide Translocator 3",
"url": "https://questionsmedicales.fr/mesh/D033781",
"about": {
"@type": "MedicalCondition",
"name": "Translocateur-3 de nucléotides adényliques",
"code": {
"@type": "MedicalCode",
"code": "D033781",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500.300"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Translocateur-1 de nucléotides adényliques",
"alternateName": "Adenine Nucleotide Translocator 1",
"url": "https://questionsmedicales.fr/mesh/D033741",
"about": {
"@type": "MedicalCondition",
"name": "Translocateur-1 de nucléotides adényliques",
"code": {
"@type": "MedicalCode",
"code": "D033741",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500.100"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Translocateur-2 de nucléotides adényliques",
"alternateName": "Adenine Nucleotide Translocator 2",
"url": "https://questionsmedicales.fr/mesh/D033742",
"about": {
"@type": "MedicalCondition",
"name": "Translocateur-2 de nucléotides adényliques",
"code": {
"@type": "MedicalCode",
"code": "D033742",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Translocateur-3 de nucléotides adényliques",
"alternateName": "Adenine Nucleotide Translocator 3",
"url": "https://questionsmedicales.fr/mesh/D033781",
"about": {
"@type": "MedicalCondition",
"name": "Translocateur-3 de nucléotides adényliques",
"code": {
"@type": "MedicalCode",
"code": "D033781",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.500.300"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Pore de transition de perméabilité mitochondriale",
"alternateName": "Mitochondrial Permeability Transition Pore",
"url": "https://questionsmedicales.fr/mesh/D000083162",
"about": {
"@type": "MedicalCondition",
"name": "Pore de transition de perméabilité mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D000083162",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.563"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines du complexe d'import des protéines précurseurs mitochondriales",
"alternateName": "Mitochondrial Precursor Protein Import Complex Proteins",
"url": "https://questionsmedicales.fr/mesh/D000090622",
"about": {
"@type": "MedicalCondition",
"name": "Protéines du complexe d'import des protéines précurseurs mitochondriales",
"code": {
"@type": "MedicalCode",
"code": "D000090622",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.594"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Mitochondrial Proton-Translocating ATPases",
"alternateName": "Mitochondrial Proton-Translocating ATPases",
"url": "https://questionsmedicales.fr/mesh/D025261",
"about": {
"@type": "MedicalCondition",
"name": "Mitochondrial Proton-Translocating ATPases",
"code": {
"@type": "MedicalCode",
"code": "D025261",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.625"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéines de découplage mitochondrial",
"alternateName": "Mitochondrial Uncoupling Proteins",
"url": "https://questionsmedicales.fr/mesh/D000071245",
"about": {
"@type": "MedicalCondition",
"name": "Protéines de découplage mitochondrial",
"code": {
"@type": "MedicalCode",
"code": "D000071245",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Protéine-1 de découplage",
"alternateName": "Uncoupling Protein 1",
"url": "https://questionsmedicales.fr/mesh/D000071256",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-2 de découplage",
"alternateName": "Uncoupling Protein 2",
"url": "https://questionsmedicales.fr/mesh/D000071246",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-2 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 de découplage",
"alternateName": "Uncoupling Protein 3",
"url": "https://questionsmedicales.fr/mesh/D000071247",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéine-1 de découplage",
"alternateName": "Uncoupling Protein 1",
"url": "https://questionsmedicales.fr/mesh/D000071256",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-1 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071256",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.500"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-2 de découplage",
"alternateName": "Uncoupling Protein 2",
"url": "https://questionsmedicales.fr/mesh/D000071246",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-2 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071246",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Protéine-3 de découplage",
"alternateName": "Uncoupling Protein 3",
"url": "https://questionsmedicales.fr/mesh/D000071247",
"about": {
"@type": "MedicalCondition",
"name": "Protéine-3 de découplage",
"code": {
"@type": "MedicalCode",
"code": "D000071247",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.688.875"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Canal anionique-1 voltage-dépendant",
"alternateName": "Voltage-Dependent Anion Channel 1",
"url": "https://questionsmedicales.fr/mesh/D050995",
"about": {
"@type": "MedicalCondition",
"name": "Canal anionique-1 voltage-dépendant",
"code": {
"@type": "MedicalCode",
"code": "D050995",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.750"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Canal anionique-2 voltage-dépendant",
"alternateName": "Voltage-Dependent Anion Channel 2",
"url": "https://questionsmedicales.fr/mesh/D050996",
"about": {
"@type": "MedicalCondition",
"name": "Canal anionique-2 voltage-dépendant",
"code": {
"@type": "MedicalCode",
"code": "D050996",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.750.875"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Protéine trifonctionnelle mitochondriale",
"alternateName": "Mitochondrial Trifunctional Protein",
"url": "https://questionsmedicales.fr/mesh/D063991",
"about": {
"@type": "MedicalCondition",
"name": "Protéine trifonctionnelle mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D063991",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.765"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sous-unité alpha de la protéine trifonctionnelle mitochondriale",
"alternateName": "Mitochondrial Trifunctional Protein, alpha Subunit",
"url": "https://questionsmedicales.fr/mesh/D063992",
"about": {
"@type": "MedicalCondition",
"name": "Sous-unité alpha de la protéine trifonctionnelle mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D063992",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.765.200"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sous-unité bêta de la protéine trifonctionnelle mitochondriale",
"alternateName": "Mitochondrial Trifunctional Protein, beta Subunit",
"url": "https://questionsmedicales.fr/mesh/D063993",
"about": {
"@type": "MedicalCondition",
"name": "Sous-unité bêta de la protéine trifonctionnelle mitochondriale",
"code": {
"@type": "MedicalCode",
"code": "D063993",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.765.500"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Nucleoside diphosphate kinase D",
"alternateName": "Nucleoside Diphosphate Kinase D",
"url": "https://questionsmedicales.fr/mesh/D061107",
"about": {
"@type": "MedicalCondition",
"name": "Nucleoside diphosphate kinase D",
"code": {
"@type": "MedicalCode",
"code": "D061107",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.781"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Peroxiredoxin III",
"alternateName": "Peroxiredoxin III",
"url": "https://questionsmedicales.fr/mesh/D061105",
"about": {
"@type": "MedicalCondition",
"name": "Peroxiredoxin III",
"code": {
"@type": "MedicalCode",
"code": "D061105",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.812"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Prohibitines",
"alternateName": "Prohibitins",
"url": "https://questionsmedicales.fr/mesh/D000091402",
"about": {
"@type": "MedicalCondition",
"name": "Prohibitines",
"code": {
"@type": "MedicalCode",
"code": "D000091402",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.844"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Sirtuine-3",
"alternateName": "Sirtuin 3",
"url": "https://questionsmedicales.fr/mesh/D056566",
"about": {
"@type": "MedicalCondition",
"name": "Sirtuine-3",
"code": {
"@type": "MedicalCode",
"code": "D056566",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D12.776.575.875"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Protéines mitochondriales",
"alternateName": "Mitochondrial Proteins",
"code": {
"@type": "MedicalCode",
"code": "D024101",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Thomas Becker",
"url": "https://questionsmedicales.fr/author/Thomas%20Becker",
"affiliation": {
"@type": "Organization",
"name": "Institute of Biochemistry und Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany."
}
},
{
"@type": "Person",
"name": "Johannes M Herrmann",
"url": "https://questionsmedicales.fr/author/Johannes%20M%20Herrmann",
"affiliation": {
"@type": "Organization",
"name": "Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany. Electronic address: hannes.herrmann@biologie.uni-kl.de."
}
},
{
"@type": "Person",
"name": "Timothy E Shutt",
"url": "https://questionsmedicales.fr/author/Timothy%20E%20Shutt",
"affiliation": {
"@type": "Organization",
"name": "Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada."
}
},
{
"@type": "Person",
"name": "Cole M Haynes",
"url": "https://questionsmedicales.fr/author/Cole%20M%20Haynes",
"affiliation": {
"@type": "Organization",
"name": "Molecular, Cell and Cancer Biology, UMass-Chan Medical School, Worcester, MA 01655, USA."
}
},
{
"@type": "Person",
"name": "Yang Yang",
"url": "https://questionsmedicales.fr/author/Yang%20Yang",
"affiliation": {
"@type": "Organization",
"name": "Stem Cells and Metabolism Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Updates in Small Interfering RNA for the Treatment of Dyslipidemias.",
"datePublished": "2023-10-04",
"url": "https://questionsmedicales.fr/article/37792132",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11883-023-01156-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Small Interfering RNA to Reduce Lipoprotein(a) in Cardiovascular Disease.",
"datePublished": "2022-11-06",
"url": "https://questionsmedicales.fr/article/36342163",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1056/NEJMoa2211023"
}
},
{
"@type": "ScholarlyArticle",
"name": "Small interfering RNA: Discovery, pharmacology and clinical development-An introductory review.",
"datePublished": "2022-11-13",
"url": "https://questionsmedicales.fr/article/36250252",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/bph.15972"
}
},
{
"@type": "ScholarlyArticle",
"name": "Elucidating the nanostructure of small interfering RNA-loaded lipidoid-polymer hybrid nanoparticles.",
"datePublished": "2022-11-28",
"url": "https://questionsmedicales.fr/article/36508398",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.jcis.2022.11.141"
}
},
{
"@type": "ScholarlyArticle",
"name": "Transgene Silencing, RNA Interference, and the Antiviral Defense Mechanism Directed by Small Interfering RNAs.",
"datePublished": "2023-04-26",
"url": "https://questionsmedicales.fr/article/36441873",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1094/PHYTO-10-22-0358-IA"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides aminés, peptides et protéines",
"item": "https://questionsmedicales.fr/mesh/D000602"
},
{
"@type": "ListItem",
"position": 3,
"name": "Protéines",
"item": "https://questionsmedicales.fr/mesh/D011506"
},
{
"@type": "ListItem",
"position": 4,
"name": "Protéines mitochondriales",
"item": "https://questionsmedicales.fr/mesh/D024101"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Protéines mitochondriales - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Protéines mitochondriales",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Protéines mitochondriales",
"description": "Comment diagnostiquer une dysfonction mitochondriale ?\nQuels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?\nQuels symptômes indiquent une maladie mitochondriale ?\nLes tests génétiques sont-ils fiables pour les maladies mitochondriales ?\nQuel rôle joue l'imagerie dans le diagnostic mitochondrial ?",
"url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=RNA,+Small+Interfering#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Protéines mitochondriales",
"description": "Quels sont les symptômes courants des maladies mitochondriales ?\nLes troubles cognitifs sont-ils liés aux protéines mitochondriales ?\nComment la myopathie mitochondriale se manifeste-t-elle ?\nLes troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?\nLes symptômes varient-ils selon l'âge d'apparition ?",
"url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=RNA,+Small+Interfering#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Protéines mitochondriales",
"description": "Peut-on prévenir les maladies mitochondriales ?\nL'exercice physique peut-il réduire les risques ?\nLes antioxydants jouent-ils un rôle préventif ?\nUne alimentation équilibrée est-elle importante ?\nLes dépistages précoces sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=RNA,+Small+Interfering#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Protéines mitochondriales",
"description": "Quels traitements sont disponibles pour les maladies mitochondriales ?\nLes coenzymes Q10 sont-elles bénéfiques ?\nLa thérapie génique est-elle une option pour ces maladies ?\nLes régimes alimentaires peuvent-ils aider ?\nLes traitements varient-ils selon le type de maladie mitochondriale ?",
"url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=RNA,+Small+Interfering#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Protéines mitochondriales",
"description": "Quelles complications peuvent survenir avec les maladies mitochondriales ?\nLes maladies mitochondriales peuvent-elles affecter la fertilité ?\nLes complications peuvent-elles être gérées ?\nLes maladies mitochondriales augmentent-elles le risque de cancer ?\nLes complications cardiovasculaires sont-elles fréquentes ?",
"url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=RNA,+Small+Interfering#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Protéines mitochondriales",
"description": "Quels sont les facteurs de risque pour les maladies mitochondriales ?\nL'âge est-il un facteur de risque ?\nLes facteurs environnementaux influencent-ils les maladies mitochondriales ?\nLe stress oxydatif est-il un facteur de risque ?\nLes habitudes alimentaires peuvent-elles influencer le risque ?",
"url": "https://questionsmedicales.fr/mesh/D024101?mesh_terms=RNA,+Small+Interfering#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une dysfonction mitochondriale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic peut inclure des tests génétiques, des biopsies musculaires et des analyses biochimiques."
}
},
{
"@type": "Question",
"name": "Quels tests sanguins sont utilisés pour évaluer les protéines mitochondriales ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests de lactate, pyruvate et des enzymes spécifiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une maladie mitochondriale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, faiblesse musculaire, troubles neurologiques et problèmes cardiaques peuvent indiquer une maladie."
}
},
{
"@type": "Question",
"name": "Les tests génétiques sont-ils fiables pour les maladies mitochondriales ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les tests génétiques peuvent identifier des mutations spécifiques liées aux maladies mitochondriales."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'imagerie dans le diagnostic mitochondrial ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'imagerie par résonance magnétique (IRM) peut aider à visualiser des anomalies cérébrales."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants des maladies mitochondriales ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, douleurs musculaires, troubles de la vision et épilepsie."
}
},
{
"@type": "Question",
"name": "Les troubles cognitifs sont-ils liés aux protéines mitochondriales ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles cognitifs peuvent survenir en raison de dysfonctionnements mitochondriaux."
}
},
{
"@type": "Question",
"name": "Comment la myopathie mitochondriale se manifeste-t-elle ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle se manifeste par une faiblesse musculaire, des crampes et une intolérance à l'exercice."
}
},
{
"@type": "Question",
"name": "Les troubles cardiaques sont-ils fréquents dans les maladies mitochondriales ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des cardiomyopathies peuvent se développer en raison de dysfonctionnements mitochondriaux."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge d'apparition ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier considérablement selon l'âge d'apparition de la maladie."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les maladies mitochondriales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines maladies génétiques ne peuvent pas être prévenues, mais un mode de vie sain aide."
}
},
{
"@type": "Question",
"name": "L'exercice physique peut-il réduire les risques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exercice régulier peut améliorer la santé mitochondriale et réduire les risques."
}
},
{
"@type": "Question",
"name": "Les antioxydants jouent-ils un rôle préventif ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les antioxydants peuvent protéger les mitochondries des dommages oxydatifs."
}
},
{
"@type": "Question",
"name": "Une alimentation équilibrée est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments soutient la santé mitochondriale."
}
},
{
"@type": "Question",
"name": "Les dépistages précoces sont-ils recommandés ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le dépistage précoce peut aider à identifier les risques et à intervenir rapidement."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les maladies mitochondriales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des suppléments, des thérapies symptomatiques et des approches nutritionnelles."
}
},
{
"@type": "Question",
"name": "Les coenzymes Q10 sont-elles bénéfiques ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le coenzyme Q10 peut améliorer la fonction mitochondriale et réduire les symptômes."
}
},
{
"@type": "Question",
"name": "La thérapie génique est-elle une option pour ces maladies ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La thérapie génique est en recherche, mais elle pourrait offrir des solutions futures."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires peuvent-ils aider ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des régimes spécifiques peuvent soutenir la fonction mitochondriale et améliorer les symptômes."
}
},
{
"@type": "Question",
"name": "Les traitements varient-ils selon le type de maladie mitochondriale ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les traitements doivent être adaptés au type spécifique de maladie mitochondriale."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les maladies mitochondriales ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des troubles neurologiques, cardiaques et endocriniens."
}
},
{
"@type": "Question",
"name": "Les maladies mitochondriales peuvent-elles affecter la fertilité ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies mitochondriales peuvent entraîner des problèmes de fertilité."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être gérées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées avec des traitements symptomatiques appropriés."
}
},
{
"@type": "Question",
"name": "Les maladies mitochondriales augmentent-elles le risque de cancer ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent un lien entre dysfonction mitochondriale et risque accru de cancer."
}
},
{
"@type": "Question",
"name": "Les complications cardiovasculaires sont-elles fréquentes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies mitochondriales peuvent entraîner des cardiomyopathies et d'autres complications."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les maladies mitochondriales ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents familiaux, des mutations génétiques et des expositions environnementales."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies mitochondriales se manifestent plus fréquemment avec l'âge."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux influencent-ils les maladies mitochondriales ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des toxines peut augmenter le risque de dysfonction mitochondriale."
}
},
{
"@type": "Question",
"name": "Le stress oxydatif est-il un facteur de risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress oxydatif peut endommager les mitochondries et contribuer à des maladies."
}
},
{
"@type": "Question",
"name": "Les habitudes alimentaires peuvent-elles influencer le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation pauvre en nutriments peut augmenter le risque de dysfonction mitochondriale."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 07/04/2025
Contenu vérifié selon les dernières recommandations médicales
3 publications dans cette catégorie
Affiliations :
Institute of Biochemistry und Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany.
CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany.
Publications dans "Protéines mitochondriales" :
3 publications dans cette catégorie
Affiliations :
Cell Biology, University of Kaiserslautern, Kaiserslautern, Germany. Electronic address: hannes.herrmann@biologie.uni-kl.de.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Biology, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Alberta Children's Hospital Research Institute, University of Calgary, Calgary, AB T2N 4N1, Canada.
Department of Medical Genetics, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, AB T2N 4N1, Canada.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Molecular, Cell and Cancer Biology, UMass-Chan Medical School, Worcester, MA 01655, USA.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Stem Cells and Metabolism Research Program, Research Programs Unit, Faculty of Medicine, University of Helsinki, 00014 Helsinki, Finland.
School of Life and Health Sciences, Faculty of Science, The Chinese University of Hong Kong, 518172 Shenzhen, China.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel. Electronic address: maya.schuldiner@weizmann.ac.il.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Systems Medicine, Faculty of Medicine, Goethe University, Frankfurt am Main, Germany; Cardio-Pulmonary Institute, Frankfurt am Main, Germany. Electronic address: ch.muench@em.uni-frankfurt.de.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Institute of Biology II, Biochemistry and Functional Proteomics, Faculty of Biology, University of Freiburg, Freiburg, Germany.
Signalling Research Centres BIOSS and CIBSS, University of Freiburg, Freiburg, Germany.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Institute of Molecular Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, University Avenue, Glasgow, G12 8QQ Scotland, UK.
Department for Chemistry, Institute for Biochemistry, University of Cologne, 50674 Cologne, Germany.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Molecular Genetics, University of Kaiserslautern, 67663 Kaiserslautern, Germany.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany. Electronic address: nikolaus.pfanner@biochemie.uni-freiburg.de.
Publications dans "Protéines mitochondriales" :
2 publications dans cette catégorie
Affiliations :
Institute of Biochemistry and Molecular Biology, ZBMZ, Faculty of Medicine, University of Freiburg, 79104 Freiburg, Germany; CIBSS Centre for Integrative Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany; BIOSS Centre for Biological Signalling Studies, University of Freiburg, 79104 Freiburg, Germany. Electronic address: nils.wiedemann@biochemie.uni-freiburg.de.
Publications dans "Protéines mitochondriales" :
1 publication dans cette catégorie
Affiliations :
University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :
1 publication dans cette catégorie
Affiliations :
University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :
1 publication dans cette catégorie
Affiliations :
University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :
1 publication dans cette catégorie
Affiliations :
University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Washington University in St. Louis, Brown School, St. Louis, MO, United States.
Publications dans "Protéines mitochondriales" :
1 publication dans cette catégorie
Affiliations :
University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
University of South Florida, Department of Molecular Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :
1 publication dans cette catégorie
Affiliations :
University of South Florida, Division of Allergy and Immunology, Department of Internal Medicine, College of Medicine, Tampa, FL, United States.
Publications dans "Protéines mitochondriales" :
Atherosclerotic cardiovascular disease (ASCVD) is still the leading cause of death worldwide. Despite excellent pharmacological approaches, clinical registries consistently show that many people with ...
The safety and efficacy of LDL-C lowering with the siRNA inclisiran has been documented in the open-label ORION-3 trial, with a follow-up of 4 years. While the outcome trial is pending, a pooled analy...
Lipoprotein(a) is a presumed risk factor for atherosclerotic cardiovascular disease. Olpasiran is a small interfering RNA that reduces lipoprotein(a) synthesis in the liver....
We conducted a randomized, double-blind, placebo-controlled, dose-finding trial involving patients with established atherosclerotic cardiovascular disease and a lipoprotein(a) concentration of more th...
Among the 281 enrolled patients, the median concentration of lipoprotein(a) at baseline was 260.3 nmol per liter, and the median concentration of low-density lipoprotein cholesterol was 67.5 mg per de...
Olpasiran therapy significantly reduced lipoprotein(a) concentrations in patients with established atherosclerotic cardiovascular disease. Longer and larger trials will be necessary to determine the e...
Post-transcriptional gene silencing targets and degrades mRNA transcripts, silencing the expression of specific genes. RNA interference technology, using synthetic structurally well-defined short doub...
We analyzed the structural and material properties of small interfering RNA (siRNA)-loaded lipid-polymer hybrid nanoparticles (LPNs) containing ionizable lipidoid and poly(dl-lactic-co-glycolic acid) ...
One important discovery in plant pathology over recent decades is the natural antiviral defense mechanism mediated by RNA interference (RNAi). In antiviral RNAi, virus infection triggers Dicer process...
The fact that cancer is one of the leading causes of death requires researchers to create new systems of effective treatment for malignant tumors. One promising area is genetic therapy that uses small...
RNA has emerged as a revolutionary and important tool in the battle against emerging infectious diseases, with roles extending beyond its applications in vaccines, in which it is used in the response ...
Iron-dependent ferroptosis is a promising therapeutic strategy for cancers. However, the sustained overexpression of the antioxidant glutathione (GSH) in cancer cells substantially limits its therapeu...
Transcriptional gene silencing by small interfering RNAs (siRNAs) has been widely described in various species, including plants and yeast. In mammals, its extent remains somewhat debated. Previous st...
Cisplatin-based chemotherapy plays a vital role in the management of muscle-invasive bladder cancer (MIBC); however, off-tumor toxicity and resistance often lead to cancer recurrence and eventual trea...